Publications by authors named "Maria Mendonca Torres"

Claim this Profile
D
Differentiated Thyroid Cancer in Severe Insulin Resistance.
Yevgeniya Kushchayeva, Vasyl Vasko, Kirk Jensen, Maria Cecilia Mendonca Torres, Jennifer E Dwyer

AACE Endocrinol Diabetes· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sex-Specific Expression of Histone Lysine Demethylases (KDMs) in Thyroid Cancer.
Leila Shobab, Hui Zheng, Kirk Jensen, Maria Cecilia Mendonca-Torres, Matthew McCoy

Cancers (Basel)· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and molecular characterization of thyroid cancer when seen as a second malignant neoplasm.
Kristen Romanelli, Justin Wells, Aneeta Patel, Maria Mendonca Torres, John Costello

Ther Adv Endocrinol Metab· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytochrome C Oxidase Subunit 4 (COX4): A Potential Therapeutic Target for the Treatment of Medullary Thyroid Cancer.
Athanasios Bikas, Kirk Jensen, Aneeta Patel, John Costello, Sarah M Reynolds, Maria Cecilia Mendonca-Torres

Cancers (Basel)· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection of BRAFV600E in Liquid Biopsy from Patients with Papillary Thyroid Cancer Is Associated with Tumor Aggressiveness and Response to Therapy.
Kirk Jensen, Shilpa Thakur, Aneeta Patel, Maria Cecilia Mendonca-Torres, John Costello

J Clin Med· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Microfluidic Droplet Digital PCR Is a Powerful Tool for Detection of BRAF and TERT Mutations in Papillary Thyroid Carcinomas.
Dorina Ylli, Aneeta Patel, Kirk Jensen, Zhao-Zhang Li, Maria Cecilia Mendonca-Torres

Cancers (Basel)· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The translocator protein (TSPO) ligand PK11195 induces apoptosis and cell cycle arrest and sensitizes to chemotherapy treatment in pre- and post-relapse neuroblastoma cell lines.
Maria C Mendonça-Torres, Stephen S Roberts

Cancer Biol Ther· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GABA receptor expression in benign and malignant thyroid tumors.
Stephen S Roberts, Maria Cecilia Mendonça-Torres, Kirk Jensen, Gary L Francis, Vasyl Vasko

Pathol Oncol Res· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis